8.1 Organophosphates, Carbamates, Pyrethroids, and Cholinesterase Antidotes

Pesticides are among the most acutely toxic agricultural, industrial, and household chemicals encountered in clinical toxicology. Worldwide, acute pesticide exposures—predominantly intentional ingestions of organophosphates and carbamates—account for hundreds of thousands of fatalities annually. For the specialist in poison information, managing these exposures requires rapid recognition of multi-receptor autonomic hyperstimulation, aggressive physiological titration of antidotes, anticipation of delayed neuromuscular respiratory failure, and strict adherence to counterintuitive resuscitation principles.

---

Biochemical Mechanisms: Organophosphates vs. Carbamates

Acetylcholinesterase (AChE) is the physiological serine hydrolase anchored to synaptic membranes in cholinergic synapses and erythrocyte membranes. It terminates neurotransmission by rapidly hydrolyzing acetylcholine (ACh) into acetic acid and choline. When xenobiotics inhibit AChE, acetylcholine accumulates in massive excess across three distinct anatomical sites: postganglionic parasympathetic neuroeffector junctions (muscarinic), autonomic ganglia and somatic neuromuscular junctions (nicotinic), and central nervous system synapses.

Normal Synapse:   AChE + Acetylcholine ──> Acetylated AChE ──> Rapid Hydrolysis (Microseconds) ──> Free AChE
Organophosphate: AChE + OP ───────────> Phosphorylated AChE ──> Stable Bond ──> Aging (Permanent)
Carbamate:       AChE + Carbamate ────> Carbamylated AChE   ──> Spontaneous Hydrolysis (Hours) ──> Free AChE

Organophosphates: Phosphorylation and the Aging Phenomenon

Organophosphorus compounds (e.g., malathion, parathion, diazinon, chlorpyrifos, dimethoate, and chemical nerve agents such as sarin, soman, tabun, and VX) contain a central phosphorus atom bound to an oxygen or sulfur double bond and leaving groups.

1. Phosphorylation: The organophosphate molecule enters the active catalytic gorge of AChE and covalently binds to the hydroxyl group of the serine-203 residue at the esteratic site. This covalent phosphorylation inhibits the enzyme's catalytic machinery.
2. Aging: Once the enzyme is phosphorylated, it can undergo a spontaneous non-enzymatic chemical reaction known as aging. Aging involves the dealkylation (loss of an alkoxy side chain) from the phosphorylated enzyme complex. This leaves a negatively charged oxygen atom that forms an exceptionally stable, irreversible covalent conformation with the catalytic pocket.
3. Clinical Implication of Aging: Once an AChE enzyme has aged, oxime antidotes (such as pralidoxime) can no longer dislodge the organophosphate moiety; recovery requires de novo synthesis of new enzyme, which takes weeks to months. The half-life of aging varies dramatically by chemical structure:
   • Soman (GD): Ages within 1 to 2 minutes.
   • Sarin (GB): Ages over approximately 3 to 5 hours.
   • Dimethyl organophosphates (e.g., malathion, dimethoate, dichlorvos): Aging half-life of roughly 3 to 4 hours, so most enzyme is aged within about 12 to 24 hours.
   • Diethyl organophosphates (e.g., parathion, chlorpyrifos, diazinon): Aging half-life of roughly 30 to 35 hours, so oximes can still help for a day or more.

Carbamates: Reversible Carbamylation

Carbamates (e.g., aldicarb, carbaryl/Sevin, methomyl, propoxur, bendiocarb) are N-methyl or N,N-dimethyl carbamic acid esters. They also bind the esteratic serine residue of AChE, forming a carbamylated enzyme complex.

• Spontaneous Hydrolysis: Unlike the phosphorylated bond, the carbamylated serine bond is transient and unstable. The carbamate-AChE complex undergoes spontaneous decarbamylation (hydrolysis) with an elimination half-life of 30 minutes to a few hours (typically clearing within 24 to 48 hours).
• No Aging: Carbamylated acetylcholinesterase never undergoes aging. Consequently, carbamate poisoning is characteristically self-limiting, provided the patient receives adequate respiratory support and atropinization during the acute peak of toxicity.

---

The Cholinergic Toxidrome: Muscarinic, Nicotinic, and Central Effects

Accumulation of excessive acetylcholine produces profound autonomic chaos. Clinical toxicity is divided into three receptor domains: muscarinic, nicotinic, and central nervous system.

1. Muscarinic Manifestations: Hypersecretion and the Killer B's

Muscarinic receptors (M₁ through M₅) are located on postganglionic parasympathetic effector cells (glands, smooth muscle, cardiac conduction tissue). Stimulation produces generalized glandular hypersecretion and smooth muscle contraction.

Two classic clinical mnemonics summarize these findings:

• SLUDGEM: Salivation, Lacrimation, Urination, Defecation, Gastrointestinal cramping, Emesis, Miosis.
• DUMBELS: Diarrhea, Urination, Miosis, Bradycardia / Bronchorrhea / Bronchospasm, Emesis, Lacrimation, Salivation.

THE KILLER B'S (PRIMARY CAUSE OF MORTALITY): The lethal triad of cholinergic poisoning consists of Bronchorrhea (massive, flood-like hypersecretion of watery fluid into the tracheobronchial tree), Bronchospasm (severe smooth muscle constriction of the airways), and Bradycardia (sinus arrest, junctional rhythms, or severe AV nodal block). Patients literally drown in their own pulmonary secretions if immediate atropinization is not achieved.

2. Nicotinic Manifestations: Ganglia and Neuromuscular Junctions

Nicotinic receptors are ligand-gated ion channels located at autonomic ganglia (sympathetic and parasympathetic) and the somatic neuromuscular junction (NMJ):

• Autonomic Ganglionic Stimulation: Both sympathetic and parasympathetic ganglia are activated simultaneously. In many acute ingestions, sympathetic ganglionic firing predominates initially, causing tachycardia, hypertension, and pallor. Clinical Caveat: Tachycardia does NOT exclude cholinergic toxicity! Relying on bradycardia to make the diagnosis is a dangerous error.
• Somatic Neuromuscular Junction (NM) Overstimulation: Acetylcholine binds motor endplate nicotinic receptors, initially triggering involuntary motor unit firing (muscle fasciculations, coarse twitching, and cramps). Prolonged depolarization then produces a depolarizing neuromuscular blockade, leading to severe generalized muscle weakness, flaccid paralysis, and diaphragmatic/intercostal respiratory arrest.
• Nicotinic Mnemonic (MTWTF): Mydriasis / Muscle fasciculations, Tachycardia, Weakness, Tremors / Twitching, Fasciculations / Flaccid paralysis.

3. Central Nervous System (CNS) Manifestations

Lipophilic organophosphates readily cross the blood-brain barrier, stimulating central muscarinic and nicotinic receptors. Manifestations include agitation, confusion, delirium, ataxia, generalized tonic-clonic seizures, status epilepticus, central hypoventilation, and profound coma. Continuous central seizure activity induces secondary excitotoxic brain injury; aggressive GABA-mediated anticonvulsant therapy with intravenous benzodiazepines (e.g., diazepam, midazolam) is mandatory.

---

Targeted Antidote Pharmacotherapy: Atropine and Pralidoxime

Resuscitation of cholinesterase inhibitor poisoning relies on a synergistic two-antidote strategy: muscarinic receptor blockade with atropine, combined with enzymatic reactivation of acetylcholinesterase using pralidoxime.

Atropine: Muscarinic Receptor Antagonist

Atropine is a competitive, reversible antagonist at central and peripheral muscarinic acetylcholine receptors. It has zero activity at nicotinic receptors; therefore, atropine will not reverse muscle fasciculations, peripheral muscle weakness, or diaphragmatic paralysis.

The Rule of Atropine Titration: The Pulmonary Endpoint

In poisoned patients, standard Advanced Cardiac Life Support (ACLS) doses (0.5 to 1.0 mg) are completely ineffective. Resuscitation requires rapid, aggressive escalation:

• Initial Adult Dose: Administer 1 to 2 mg IV push (pediatric dose: 0.02 to 0.05 mg/kg IV).
• Rapid Dose Doubling: If pulmonary secretions do not dry within 3 to 5 minutes, double the previous dose (e.g., 2 mg, then 4 mg, 8 mg, 16 mg, 32 mg...).
• The True Therapeutic Endpoint: Atropine is titrated strictly to pulmonary endpoints: clearing of tracheobronchial secretions (drying of bronchorrhea), resolution of bronchospasm (improved air entry and clearing of wheezes), and adequate oxygenation (SpO2 > 90% without pink frothy sputum).

CRITICAL CLINICAL PEARL (WHAT NOT TO TITRATE TO):

• DO NOT titrate to pupil size (mydriasis): Miosis can persist for days due to direct ocular vapor absorption or slow central clearance, long after the lungs are dry. Over-titrating to achieve dilated pupils causes lethal atropine toxicity (hyperthermia, delirium, ileus).
• DO NOT titrate to heart rate: Patients may already be tachycardic from sympathetic ganglionic firing or severe hypoxia. Atropine must be administered even if the patient is tachycardic if their lungs are wet with secretions.

Maintenance Atropine Infusion

Severe organophosphate poisoning can consume hundreds to thousands of milligrams of atropine over 48 to 72 hours. Once initial atropinization (dry pulmonary tree) is established, start a continuous intravenous infusion at 10% to 20% of the total cumulative dose required to stabilize the patient, delivered per hour (e.g., if 40 mg was required to dry secretions, initiate infusion at 4 to 8 mg/hour). Down-titrate carefully as symptoms stabilize.

Pralidoxime (2-PAM): Acetylcholinesterase Reactivator

Pralidoxime chloride (2-PAM) is a nucleophilic oxime compound designed to restore intrinsic enzymatic function:

1. Mechanism: 2-PAM binds to the uninhibited anionic site of acetylcholinesterase. Its nucleophilic oxime moiety (=N-OH) attacks the phosphorus atom covalently bound to the esteratic serine-203, forming an oxime-phosphonate complex that dissociates from the enzyme, freeing the regenerated serine hydroxyl group.
2. Nicotinic Reversal: Because 2-PAM restores active AChE at the somatic motor endplate, it is the only antidote that reverses nicotinic muscle weakness, fasciculations, and diaphragmatic paralysis.
3. Administration Timing & Precautions:
   • Administer Early: 2-PAM must be delivered before enzyme aging occurs.
   • Always Pair with Atropine: 2-PAM should never be given without atropine. In severe poisoning, administering 2-PAM alone can cause transient worsening of cholinergic symptoms due to weak intrinsic anticholinesterase properties or acute shifts in neurotransmitter balance.
   • Dosing Regimen: Administer an initial loading dose of 1 to 2 g IV in adults (pediatric: 20 to 50 mg/kg, maximum 2 g) diluted in 100 mL normal saline and infused over 15 to 30 minutes. Rapid IV push boluses can provoke transient hypertension, laryngeal spasm, and depolarizing neuromuscular blockade. Follow with a continuous infusion of 500 mg/hour in adults (pediatric: 10 to 20 mg/kg/hour) maintained until the patient is weaned from mechanical ventilation and atropine is discontinued.

---

Delayed Neurological Complications: IMS vs. OPIDN

Survivors of acute organophosphate exposure remain vulnerable to two distinct, delayed neurological syndromes with completely different timeframes and pathophysiologic mechanisms.

---

Pyrethrins and Pyrethroids: Sodium Channel Toxicity

Pyrethrins are natural insecticidal esters derived from the flowers of Chrysanthemum cinerariifolium. Pyrethroids are synthetic chemical analogs modified for greater environmental persistence and insecticidal potency. They are frequently co-formulated with piperonyl butoxide (PBO), a synergist that inhibits insect cytochrome P450 enzymes to prevent xenobiotic clearance.

Classification and Mechanism

• Type I Pyrethroids (lack an alpha-cyano moiety; e.g., permethrin, allethrin, resmethrin): Prolong the open state of voltage-gated sodium channels (Nav) during nerve membrane excitation, causing repetitive electrical afterdischarges.
• Type II Pyrethroids (contain an alpha-cyano-3-phenoxybenzyl group; e.g., deltamethrin, cypermethrin, fenvalerate, lambda-cyhalothrin): Hold sodium channels open for dramatically longer durations, producing prolonged membrane depolarization, conduction block, and inhibition of GABA-A chloride channels.

Clinical Manifestations and Treatment

• Cutaneous Paresthesias: Direct skin contact produces intense, distressing facial and hand paresthesias characterized by stinging, burning, tingling, or numbness without visible erythema or chemical burns. Symptoms peak at 6 to 12 hours.
• Topical Vitamin E Cream: The specific antidote for cutaneous pyrethroid paresthesias is topical dl-alpha-tocopheryl acetate (Vitamin E) cream. Topical vitamin E is reported to relieve the paresthesias; the mechanism is not established (membrane stabilization and antioxidant effects are proposed).
• Systemic Toxicity: Massive oral ingestions (primarily Type II) cause nausea, vomiting, hypersalivation, choreoathetosis, fasciculations, pulmonary edema, and generalized seizures. Treatment is supportive; administer intravenous benzodiazepines for seizures. (Atropine and pralidoxime have no role).

---

Herbicides: Paraquat and the Oxygen Restriction Rule

Paraquat (1,1'-dimethyl-4,4'-bipyridinium dichloride) is a non-selective bipyridyl contact herbicide. It is one of the most lethal poisons known; ingestion of as little as 10 to 20 mL of a 20% solution carries a mortality rate exceeding 60% to 80%.

Paraquat Ingestion ──> Polyamine Transporter ──> Alveolar Pneumocyte Accumulation (10–20x Plasma)
Redox Cycling:     Paraquat (PQ2+) + NADPH ──> PQ+• + O2 ──> Superoxide (O2-•) + H2O2 + Hydroxyl (OH•)
Tissue Damage:     Lipid Peroxidation ──> Pulmonary Alveolitis ──> Progressive Irreversible Fibrosis

Pathophysiology of the 'Paraquat Lung'

1. Selective Pulmonary Sequestration: Alveolar type I and type II pneumocytes possess an active polyamine diamine transport system (intended for putrescine and spermidine). Paraquat's bipyridyl structure mimics polyamines, causing the lung to actively concentrate paraquat against a steep chemical gradient, reaching intracellular concentrations 10 to 20 times higher than plasma levels.
2. Redox Cycling and Free Radical Generation: Inside pneumocytes, paraquat (PQ²⁺) is enzymatically reduced by cellular NADPH-cytochrome P450 reductase to form a monocation free radical (PQ⁺•). This radical immediately reacts with ambient molecular oxygen (O₂), transferring its electron to generate a superoxide anion (O₂⁻•) while regenerating parent paraquat (PQ²⁺). This self-sustaining redox cycle continually consumes cellular NADPH and churns out massive quantities of cytotoxic reactive oxygen species (ROS), including hydrogen peroxide and hydroxyl radicals (OH•).
3. Clinical Course: The patient initially experiences severe corrosive caustic burns of the mouth, esophagus, and stomach (pseudomembrane formation). Over 48 hours to 7 days, acute pulmonary alveolitis develops, progressing relentlessly over 2 to 3 weeks into catastrophic, irreversible pulmonary fibrosis and death from asphyxia.

The Oxygen Restriction Rule

Because molecular oxygen (O₂) is the direct substrate for redox cycling, administering supplemental oxygen violently accelerates superoxide radical generation, rapidly destroying lung tissue.

VITAL CLINICAL DIRECTIVE (OXYGEN RESTRICTION): In confirmed or suspected paraquat poisoning, STRICTLY WITHHOLD SUPPLEMENTAL OXYGEN. Patients should be maintained on room air (FiO₂ 0.21) whenever possible. Supplemental oxygen is indicated only as a terminal palliative measure or when severe, life-threatening hypoxia supervenes (PaO2 < 40 to 50 mmHg or SpO2 < 85%).

• Decontamination: Administer oral activated charcoal (1 g/kg) or Fuller's Earth (bentonite clay, 100 to 150 g in adults) within 1 to 2 hours of ingestion to bind unabsorbed herbicide in the gut lumen.

---

Clinical Poison Center Case Scenario: Organophosphate Overdose

A 48-year-old agricultural worker is brought to the emergency department 1 hour after accidentally spraying and ingesting a concentrated liquid organophosphate insecticide. The patient is diaphoretic, coughing violently, and producing massive amounts of pink, watery tracheal secretions. Vital signs: HR 48 bpm, BP 86/50 mmHg, RR 32 breaths/min, SpO2 81% on room air. Physical examination reveals pinpoint pupils (1 mm), diffuse bilateral coarse rales and rhonchi across all lung fields, visible fasciculations of the tongue, deltoids, and quadriceps, and profound generalized motor weakness.

Poison Specialist Triage and Intervention Flow

1. Immediate Personal Protective Equipment (PPE) & Decontamination: Healthcare personnel must don chemical-resistant gloves, gowns, and face shields. The patient's clothing must be immediately removed, sealed in double biohazard bags, and the skin thoroughly cleansed with soap and copious warm water to halt continuous dermal absorption.
2. Aggressive Atropine Titration: The immediate threat to life is asphyxiation from bronchorrhea and bronchospasm (the Killer B's). An initial bolus of 2 mg IV atropine is given. Secretions persist at 3 minutes; a 4 mg bolus is given. Secretions persist at 7 minutes; an 8 mg bolus is given. After a total of 14 mg over 12 minutes, breath sounds clear, tracheal suction volume plummets, heart rate rises to 92 bpm, and SpO2 improves to 94%.
3. Continuous Infusion Setup: Having established initial control with 14 mg, a continuous IV atropine infusion is initiated at 2 mg/hour (approximately 15% of the stabilizing dose per hour) and titrated to maintain clear breath sounds.
4. Pralidoxime (2-PAM) Initiation: Because the patient demonstrates prominent nicotinic signs (muscle fasciculations, diaphragmatic weakness), 2-PAM is infused: a 2 g loading dose in 100 mL NS over 20 minutes, followed by a continuous infusion of 500 mg/hour to reactivate acetylcholinesterase before aging occurs.